110 related articles for article (PubMed ID: 15856797)
1. The future of genomics: hope or hype?
Arp D
AHIP Cover; 2005; 46(2):14-7. PubMed ID: 15856797
[No Abstract] [Full Text] [Related]
2. Genomics: implications for health systems.
Myers C; Paulk N; Dudlak C
Front Health Serv Manage; 2001; 17(3):3-16. PubMed ID: 11299704
[TBL] [Abstract][Full Text] [Related]
3. Commentary 1. 'Telling the truth about genomics': hype and hope.
Boddington P
Commun Med; 2006; 3(1):93-4; discussion 99-100. PubMed ID: 16808428
[No Abstract] [Full Text] [Related]
4. Genomics and proteomics: the next generation of health care.
Sica JM
Empl Benefits J; 2002 Dec; 27(4):18-21. PubMed ID: 12500585
[TBL] [Abstract][Full Text] [Related]
5. Genetic testing and disease state management.
Kozma CM
Manag Care Interface; 2001 Nov; 14(11):54, 57. PubMed ID: 11715763
[No Abstract] [Full Text] [Related]
6. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era.
Rai AK
Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845
[TBL] [Abstract][Full Text] [Related]
7. Telling the truth about genomics.
Chadwick R
Commun Med; 2004; 1(2):193-9. PubMed ID: 16808701
[TBL] [Abstract][Full Text] [Related]
8. [Advanced genomic analyses for hypertension].
Tetsuro M
Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2090-6. PubMed ID: 16411435
[No Abstract] [Full Text] [Related]
9. How will GINA influence participation in pharmacogenomics research and clinical testing?
Dressler LG; Terry SF
Clin Pharmacol Ther; 2009 Nov; 86(5):472-5. PubMed ID: 19844223
[TBL] [Abstract][Full Text] [Related]
10. Supplements. Hope or hype?
D'Arrigo T
Diabetes Forecast; 2007; 60(3):13. PubMed ID: 17410655
[No Abstract] [Full Text] [Related]
11. Genomics and the family physician: realizing the potential.
Collins F
Am Fam Physician; 2004 Nov; 70(9):1637, 1642. PubMed ID: 15554479
[No Abstract] [Full Text] [Related]
12. What price personal genome exploration?
Fox JL
Nat Biotechnol; 2008 Oct; 26(10):1105-8. PubMed ID: 18846082
[No Abstract] [Full Text] [Related]
13. Personal genomics: information can be harmful.
Ransohoff DF; Khoury MJ
Eur J Clin Invest; 2010 Jan; 40(1):64-8. PubMed ID: 20055897
[No Abstract] [Full Text] [Related]
14. Genomics in drug discovery: the best things come to those who wait.
Bansal AT; Barnes MR
Curr Opin Drug Discov Devel; 2008 May; 11(3):303-11. PubMed ID: 18428083
[TBL] [Abstract][Full Text] [Related]
15. Information overload? As genetic testing kits sold directly to consumers gain popularity, medical professionals and lawmakers wonder if more regulation is needed.
Goodwin K
State Legis; 2008 Sep; 34(8):30-3. PubMed ID: 18754160
[No Abstract] [Full Text] [Related]
16. Ethics. Identifiability in genomic research.
Lowrance WW; Collins FS
Science; 2007 Aug; 317(5838):600-2. PubMed ID: 17673640
[No Abstract] [Full Text] [Related]
17. Do you want us to hide information or release information? Make up your mind.
Thompson RE
Physician Exec; 2006; 32(5):56-9. PubMed ID: 17007315
[No Abstract] [Full Text] [Related]
18. Unchecked by government, genetic tests sell hope and hype.
Marris E
Nat Med; 2005 Jun; 11(6):584. PubMed ID: 15937457
[No Abstract] [Full Text] [Related]
19. Integrating genomics across drug discovery and development.
Debouck C
Toxicol Lett; 2009 Apr; 186(1):9-12. PubMed ID: 18930125
[TBL] [Abstract][Full Text] [Related]
20. Genetics benefits at risk.
Nature; 2008 Feb; 451(7180):745-6. PubMed ID: 18272974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
